L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease
- PMID: 12849761
- DOI: 10.1016/s0028-3932(03)00117-9
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease
Abstract
In the current study we investigated the role of dopamine in attentional and socio-emotional functioning by examining effects of withdrawing dopaminergic medication in patients with Parkinson's disease (PD). Patients "on" medication exhibited abnormal betting strategies on a task of decision-making, reflecting impulsive behaviour and/or delay aversion, whilst the same patients "off" medication exhibited abnormally increased switch costs when switching between two tasks, reflecting attentional inflexibility. Hence, these data replicate and extend previous findings that dopaminergic medication improves or impairs cognitive performance depending on the nature of the task and the basal level of dopamine function in underlying cortico-striatal circuitry.
Similar articles
-
Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.Neuropsychologia. 2015 Aug;75:577-87. doi: 10.1016/j.neuropsychologia.2015.07.012. Epub 2015 Jul 13. Neuropsychologia. 2015. PMID: 26184442
-
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands.Cereb Cortex. 2001 Dec;11(12):1136-43. doi: 10.1093/cercor/11.12.1136. Cereb Cortex. 2001. PMID: 11709484 Clinical Trial.
-
Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.Brain. 2002 Mar;125(Pt 3):584-94. doi: 10.1093/brain/awf052. Brain. 2002. PMID: 11872615
-
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.Neurosci Biobehav Rev. 2006;30(1):1-23. doi: 10.1016/j.neubiorev.2005.03.024. Epub 2005 Jun 1. Neurosci Biobehav Rev. 2006. PMID: 15935475 Review.
-
The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.Neuropsychologia. 2016 Oct;91:163-172. doi: 10.1016/j.neuropsychologia.2016.07.032. Epub 2016 Jul 27. Neuropsychologia. 2016. PMID: 27475264 Review.
Cited by
-
Dopamine D1/D2 Receptor Activity in the Nucleus Accumbens Core But Not in the Nucleus Accumbens Shell and Orbitofrontal Cortex Modulates Risk-Based Decision Making.Int J Neuropsychopharmacol. 2015 Apr 23;18(10):pyv043. doi: 10.1093/ijnp/pyv043. Int J Neuropsychopharmacol. 2015. PMID: 25908669 Free PMC article.
-
L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease.Neuroscience. 2012 Aug 30;218:243-56. doi: 10.1016/j.neuroscience.2012.05.052. Epub 2012 Jun 1. Neuroscience. 2012. PMID: 22659568 Free PMC article.
-
Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers.Front Hum Neurosci. 2016 Oct 18;10:523. doi: 10.3389/fnhum.2016.00523. eCollection 2016. Front Hum Neurosci. 2016. PMID: 27803657 Free PMC article.
-
Computational model of precision grip in Parkinson's disease: a utility based approach.Front Comput Neurosci. 2013 Dec 2;7:172. doi: 10.3389/fncom.2013.00172. eCollection 2013. Front Comput Neurosci. 2013. PMID: 24348373 Free PMC article.
-
Neuropsychiatric and Cognitive Deficits in Parkinson's Disease and Their Modeling in Rodents.Biomedicines. 2021 Jun 17;9(6):684. doi: 10.3390/biomedicines9060684. Biomedicines. 2021. PMID: 34204380 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical